View in EDS

18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.

Saved in:
Bibliographic Details
Title: 18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.
Authors: Cochet A; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France; acochet@cgfl.fr., Besson V; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Bertaut A; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France., Fouquier A; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France., Vrigneaud JM; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Bronowicki JP; Department of Gastro-Enterology and Hepatology, University Hospital of Nancy, Nancy, France., Chevalier E; Department of Nuclear Medicine, University Hospital of Nancy, Nancy, France., Heurgue A; Department of Hepato-Gastro-Enterology, University Hospital of Reims, Reims. France., Papathanassiou D; Department of Nuclear Medicine, Institut Jean Godinot, Reims, France.; CRESTIC, University of Reims Champagne-Ardenne, Reims, France., Blanc JF; Department of Hepato-Gastro-Enterology, University Hospital of Bordeaux, Bordeaux, France., Pinaquy JB; Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France., Vincent J; Université Bourgogne Europe, Centre Georges-François Leclerc, Department of Medical Oncology, Dijon, France., Palard-Novello X; CLCC Eugène Marquis, INSERM, LTSI-UMR 1099, University of Rennes, Rennes, France., Bourien H; Department of Medical Oncology, Centre Eugene-Marquis, Rennes, France; and., Tabouret-Viaud C; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Manfredi S; Université Bourgogne Europe, University Hospital of Dijon, Department of Hepato-Gastro-Enterology, Dijon, France.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Apr 30. Date of Electronic Publication: 2026 Apr 30.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42061943
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: <superscript>18</superscript>F-FDG and <superscript>18</superscript>F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cochet+A%22">Cochet A</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France; acochet@cgfl.fr.<br /><searchLink fieldCode="AU" term="%22Besson+V%22">Besson V</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bertaut+A%22">Bertaut A</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Fouquier+A%22">Fouquier A</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Vrigneaud+JM%22">Vrigneaud JM</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bronowicki+JP%22">Bronowicki JP</searchLink>; Department of Gastro-Enterology and Hepatology, University Hospital of Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Chevalier+E%22">Chevalier E</searchLink>; Department of Nuclear Medicine, University Hospital of Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Heurgue+A%22">Heurgue A</searchLink>; Department of Hepato-Gastro-Enterology, University Hospital of Reims, Reims. France.<br /><searchLink fieldCode="AU" term="%22Papathanassiou+D%22">Papathanassiou D</searchLink>; Department of Nuclear Medicine, Institut Jean Godinot, Reims, France.; CRESTIC, University of Reims Champagne-Ardenne, Reims, France.<br /><searchLink fieldCode="AU" term="%22Blanc+JF%22">Blanc JF</searchLink>; Department of Hepato-Gastro-Enterology, University Hospital of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pinaquy+JB%22">Pinaquy JB</searchLink>; Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Vincent+J%22">Vincent J</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Department of Medical Oncology, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Palard-Novello+X%22">Palard-Novello X</searchLink>; CLCC Eugène Marquis, INSERM, LTSI-UMR 1099, University of Rennes, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Bourien+H%22">Bourien H</searchLink>; Department of Medical Oncology, Centre Eugene-Marquis, Rennes, France; and.<br /><searchLink fieldCode="AU" term="%22Tabouret-Viaud+C%22">Tabouret-Viaud C</searchLink>; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Manfredi+S%22">Manfredi S</searchLink>; Université Bourgogne Europe, University Hospital of Dijon, Department of Hepato-Gastro-Enterology, Dijon, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 Apr 30. <i>Date of Electronic Publication: </i>2026 Apr 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42061943
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.271382
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: 18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cochet A
      – PersonEntity:
          Name:
            NameFull: Besson V
      – PersonEntity:
          Name:
            NameFull: Bertaut A
      – PersonEntity:
          Name:
            NameFull: Fouquier A
      – PersonEntity:
          Name:
            NameFull: Vrigneaud JM
      – PersonEntity:
          Name:
            NameFull: Bronowicki JP
      – PersonEntity:
          Name:
            NameFull: Chevalier E
      – PersonEntity:
          Name:
            NameFull: Heurgue A
      – PersonEntity:
          Name:
            NameFull: Papathanassiou D
      – PersonEntity:
          Name:
            NameFull: Blanc JF
      – PersonEntity:
          Name:
            NameFull: Pinaquy JB
      – PersonEntity:
          Name:
            NameFull: Vincent J
      – PersonEntity:
          Name:
            NameFull: Palard-Novello X
      – PersonEntity:
          Name:
            NameFull: Bourien H
      – PersonEntity:
          Name:
            NameFull: Tabouret-Viaud C
      – PersonEntity:
          Name:
            NameFull: Manfredi S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 04
              Text: 2026 Apr 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1